W. WONGWIKROM, “A PROSPECTIVE TRIAL OF IODIXANOL 270, 320 (VISIPAQUE) IN PATIENTS WITH RENAL IMPAIRMENT (WHO HAS SERUM CREATININE BETWEEN 1.8-3.0 MH/DL.) UNDERGOING COMPUTED TOMOGRAPHY AND INTRAVENOUS PYELOGRAPHY”, ASEAN J Radiol, vol. 14, no. 1, pp. 1–4, Apr. 2023.